Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 29, Issue 6, Pages 1082-1090
Publisher
Wiley
Online
2014-09-22
DOI
10.1111/jdv.12751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving adherence to injectable disease-modifying drugs in multiple sclerosis
- (2013) Antonios Bayas Expert Opinion on Drug Delivery
- Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
- (2012) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- The potential of interleukin-17 to mediate hematopoietic response
- (2012) Aleksandra Krstic et al. IMMUNOLOGIC RESEARCH
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Adherence in the Treatment of Psoriasis: A Systematic Review
- (2011) M. Augustin et al. DERMATOLOGY
- Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ)
- (2011) Dorothy Keininger et al. Health and Quality of Life Outcomes
- IL-17 signaling in host defense against Candida albicans
- (2011) Sarah L. Gaffen et al. IMMUNOLOGIC RESEARCH
- Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis
- (2011) C. Paul et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Maximizing patient adherence for optimal outcomes in psoriasis
- (2011) A Bewley et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis — Results of the BetaPlus observational cohort study
- (2011) Carlo Pozzilli et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity
- (2009) Li Zhang et al. CLINICAL IMMUNOLOGY
- Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?
- (2009) Alessandra Lugaresi Expert Opinion on Drug Delivery
- Interleukin-17 as a drug target in human disease
- (2009) Stefan Ivanov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started